• Corpus ID: 12693663

Identification of metabolites of the cell-differentiating agent hexamethylene bisacetamide in humans.

  title={Identification of metabolites of the cell-differentiating agent hexamethylene bisacetamide in humans.},
  author={Patrick S. Callery and Merrill J. Egorin and Linda A. Geelhaar and M. S. Balachandran Nayar},
  journal={Cancer research},
  volume={46 10},
Hexamethylene bisacetamide, a compound which in vitro induces differentiation in a wide variety of human and animal cancer cell lines, is being investigated in phase I clinical trials. After i.v. administration of hexamethylene bisacetamide to humans, urine contained the parent compound and at least five metabolites formed by deacetylation and oxidation pathways. Identification of urinary metabolites was accomplished by gas chromatography-mass spectrometric analysis after isolation by ion… 

Figures and Tables from this paper

Metabolism of hexamethylene bisacetamide and its metabolites in leukemic cells.

The results document the ability of various leukemic cells to metabolize HMBA, indicate the unidirectional catabolism of that compound, and may have implications as to its mechanism of action.

The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide

It is concluded that isocarboxazid inhibits the production of 6AcHA in vivo, thus supporting the involvement of MAO in HMBA metabolism and suggesting that 6 AcHA is probably not the neurotoxic agent in dogs.

A cyclic imine intermediate in the in vitro metabolic conversion of 1,6-diaminohexane to 6-aminohexanoic acid and caprolactam.

The results indicate that the cell differentiating agent hexamethylene bisacetamide is converted into 1,6-diaminohexane, and its metabolism therefore involves diamine oxidase.

Determination of hexamethylene bisacetamide, an antineoplastic compound, in mouse and human plasma by LC-MS/MS.

Hydrophobic chromatography of the HL-60 cellular fraction co-binding with hexamethylene bisacetamide.

  • D. XieS. LiL. Ren
  • Chemistry, Biology
    Journal of chromatography. B, Biomedical sciences and applications
  • 1997

Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.

In vitro studies with HMBA provide a basis for the application of HMBA to clinical therapy of human cancers and suggests that vincristine-resistant MEL cells express a factor which circumvents essential HMBA-mediated early events.

Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.

It was apparent that the duration of HMBA exposure was an additional significant variable in predicting the magnitude of thrombocytopenia, and the maximum tolerated and recommended phase II doses for HMBA administered on this schedule were 20 and 15.8 g/m2/d, respectively.

Alkylamides as inducers of human leukemia cell differentiation: a quantitative structure-activity relationship study using comparative molecular field analysis.

Findings confirm a previous report by Langdon and Hickman that the ability to induce cell differentiation is highly dependent on molecular weight.



Studies on the mechanism of action of hexamethylene bisacetamide, a potent inducer of erythroleukemic differentiation.

  • R. Reuben
  • Biology, Chemistry
    Biochimica et biophysica acta
  • 1979

Biosynthesis of 5‐Aminopentanoic Acid and 2‐Piperidone from Cadaverine and 1‐Piperideine in Mouse

The results suggest that the metabolic fate of cadaverine may provide precursors of pharmacologically active analogues of GABA in mice liver supernatants.

A new group of potent inducers of differentiation in murine erythroleukemia cells.

A group of compounds, polymethylene bisacetamides (acetylated diamines), which are potent inducers of erythroid differentiation in murine eryTHroleukemia cells are identified and introduced through varying numbers of methylenes substantially increased the effectiveness of these compounds.

Applications of deuterium labeling in the study of the in vitro conversion of delta 1-pyrroline to 4-aminobutanoic acid and 2-pyrrolidinone.

A comparison of the amounts of product formed following incubation of labeled and unlabeled delta 1-pyrroline indicated a significant isotope effect in the formation of 2-Pyrrolidinone, suggesting that there are two separate pathways involved in the reaction.

Synthesis and oxidation of aminoalkyl-onium compounds by pig kidney diamine oxidase.

A scheme for enzyme-substrate interaction is suggested on the basis of observations of the preparation of compounds derived from diamines by replacing one amino group by a dimethylsulphonium, isothiuronium, trimethylammonium, NN'-dimethylimidazolium or N-methylpyridinium species.

Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells.

Inducers of the first class, among which were dimethyl sulfoxide and hexamethylene bisacetamide, stimulated ODC activity and were inhibited by dexamethasone and the phorbol diester, 12-O-tetradecanoylphorbol-13-acetate, but the effect of bromodeoxyuridine, which inhibits inducers of both classes, was not abrogated by polyamines.

Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds.

Effective "dimerization" of dimethyl sulfoxide through a linear polymethylene chain increases its inducing activity by a magnitude similar to that observed when N-methylacetamide is effectively dimerized in such a manner.

Deacetylation of N8-acetylspermidine by subcellular fractions of rat tissue.

  • J. Blankenship
  • Biology, Chemistry
    Archives of biochemistry and biophysics
  • 1978

Distribution, elimination, metabolism and bioavailability of hexamethylenebisacetamide in rats

SummaryHexamethylenebisacetamide (HMBA), an in vitro differentiating agent, was studied for its pharmaco-dynamic actions in animals. Plasma stability, organ distribution, excretion, oral

Protein Carboxyl Methylation Increases in Parallel With Differentiation of Neuroblastoma Cells

The data suggest that increased protein carboxyl methylation is a developmentally regulated property in neuroblastoma cells and that at least two groups of methyl acceptor proteins are induced during differentiation: a minor group related to morphological differentiation and a major group that may be related to ionic permeabilitys mechanisms of the excitable membrane.